Access cutting-edge lung cancer treatment through this clinical trial at a research site in Fountain Valley. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Fountain Valley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) and domvanalimab (AB154) compared with durvalumab plus placebo in adults with locally advanced (Stage III), unresectable NSCLC whose disease has not progressed following definitive platinum-based cCRT.
Sponsor: AstraZeneca
Check if you qualify for this lung cancer clinical trial in Fountain Valley, CA
If you're searching for lung cancer treatment options in Fountain Valley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fountain Valley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.